Back

Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: phenotyping and risk prediction Stroke in Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Chun-Chieh Wang

Chang Gung Memorial Hospital Tapei, Taipei (Taiwan)

6 More presentations in this session

Presentation thumbnail
Deep learning-based detection of paroxysmal atrial fibrillation from sinus rhythm electrocardiograms and its association with stroke risk
Doctor Y. Na (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Dynamic changes in liver fibrosis and the risk of death and bleeding in non-cirrhotic patients with atrial fibrillation treated with NOACs.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Untargeted-metabolomics identifies key metabolites for atrial fibrosis and recurrence of atrial fibrillation indication across populations
Doctor M. Chu (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Identification of new atrial fibrillation phenotypes from insertable cardiac monitor recordings using unsupervised machine learning
Doctor E. Flo Lenz (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
The prognostic value of sinus rhythm restoration in patients hospitalized for atrial fibrillation
Doctor A. Samaras (Thessaloniki, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: phenotyping and risk prediction

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
CHA2DS2-VASc vs. CHA2DS2-VA regarding their stroke risk stratifications in patients with atrial fibrillation: insights from the GLORIA-AF registry
29 August 2025
thumbnail
Congress Presentation
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
14 April 2026
thumbnail
Congress Presentation
Predicting atrial fibrillation in the real world: head-to-head comparison of five risk scores
14 April 2026
thumbnail
Congress Presentation
Evaluation of the biomarker-based ABC-AF-bleeding risk score and clinically based bleeding scores in 31,605 patients with atrial fibrillation treated with oral anticoagulation
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources